Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Malignant Brain Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00022360
What this trial is testing

Taurolidine in Treating Patients With Recurrent or Progressive Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01753713
What this trial is testing

Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
Manmeet Ahluwalia, MD 33
Testing effectiveness (Phase 2)Study completedNCT00003241
What this trial is testing

Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Texas Children's Cancer Center
Early research (Phase 1)Study completedNCT04023669
What this trial is testing

Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors

Who this might be right for
Brain TumorBrain Tumor, RecurrentBrain Tumor, Refractory+10 more
St. Jude Children's Research Hospital 21
Testing effectiveness (Phase 2)Study completedNCT00354913
What this trial is testing

Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma

Who this might be right for
GlioblastomaGliosarcoma
Duke University 21
Testing effectiveness (Phase 2)UnknownNCT00004204
What this trial is testing

Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00005859
What this trial is testing

Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 136
Testing effectiveness (Phase 2)Study completedNCT00045110
What this trial is testing

Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+6 more
National Cancer Institute (NCI) 136
Large-scale testing (Phase 3)WithdrawnNCT00083447
What this trial is testing

Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Xenova Biomedix 323
Testing effectiveness (Phase 2)Study completedNCT00006093
What this trial is testing

EMD 121974 in Treating Patients With Progressive or Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Testing effectiveness (Phase 2)Looking for participantsNCT07003542
What this trial is testing

And Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas

Who this might be right for
GlioblastomaBrain Tumor
Case Comprehensive Cancer Center 48
Testing effectiveness (Phase 2)Study completedNCT00615927
What this trial is testing

Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)

Who this might be right for
GlioblastomaGliosarcoma
Duke University 64
Testing effectiveness (Phase 2)Ended earlyNCT01310855
What this trial is testing

Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Glioblastoma
University College, London 38
Early research (Phase 1)Looking for participantsNCT04573140
What this trial is testing

RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

Who this might be right for
Adult GlioblastomaHigh Grade GliomaWHO Grade III or IV Malignant Glioma
University of Florida 28
Early research (Phase 1)Looking for participantsNCT05686798
What this trial is testing

Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.

Who this might be right for
Malignant Glioma of BrainAstrocytomaMalignant Astrocytoma+6 more
Henry Ford Health System 18
Testing effectiveness (Phase 2)Study completedNCT00641706
What this trial is testing

Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 44
Early research (Phase 1)Study completedNCT00093613
What this trial is testing

Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+2 more
National Cancer Institute (NCI) 47
Early research (Phase 1)Study completedNCT00747253
What this trial is testing

Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors

Who this might be right for
Brain TumorBrain Tumor, RecurrentBrain Neoplasm+3 more
Monteris Medical 10
Testing effectiveness (Phase 2)Study completedNCT03257631
What this trial is testing

Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors

Who this might be right for
Central Nervous System NeoplasmsMedulloblastoma
Celgene 53
Testing effectiveness (Phase 2)Study completedNCT00892177
What this trial is testing

Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Alliance for Clinical Trials in Oncology 144
Next Page